The immunological barriers to xenotransplantation

Tissue Antigens

Volumn 86, Issue 4, 2015, Pages 239-253

  Vadori, M ^a   Cozzi, E ^a,b  

^a Via dell'Università 10 ^*  (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Humoral rejection; Innate immunity; Nonhuman primates; Pig xenografts; T cell mediated rejection; Xenotransplantation

Indexed keywords

ANTIBODY; ANTIGEN; BIOMATERIAL; BORTEZOMIB; IMMUNOSUPPRESSIVE AGENT; CYTOKINE; POLYSACCHARIDE;

ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; ANTIBODY MEDIATED REJECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE; BIOCOMPATIBILITY; BIOPROSTHESIS; CELL VIABILITY; GRAFT REJECTION; GRAFT SURVIVAL; HEART VALVE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MACROPHAGE; MEDICAL DEVICE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PIG; PRIMATE MODEL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TISSUE REPAIR; XENOGRAFT; XENOTRANSPLANTATION; ANIMAL; CHEMISTRY; IMMUNOLOGY; METABOLISM; ORGAN TRANSPLANTATION; PATHOLOGY; PRIMATE; TISSUE TRANSPLANTATION; UTILIZATION;

ANIMALS; ANTIBODIES; ANTIGENS; B-LYMPHOCYTES; CYTOKINES; GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; MACROPHAGES; ORGAN TRANSPLANTATION; POLYSACCHARIDES; PRIMATES; SWINE; T-LYMPHOCYTES; TISSUE TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84942510388     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12669     Document Type: Review

References (111)

1. Zachary AA, Leffell MS. Desensitization for solid organ and hematopoietic stem cell transplantation. Immunol Rev 2014: 258: 183-207.
2. Farkash EA, Colvin RB. Diagnostic challenges in chronic antibody-mediated rejection. Nat Rev Nephrol 2012: 8: 255-7.
3. Campbell PM, Salam A, Ryan EA et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 2007: 7: 1242-8.
4. Shimizu T, Sekine H, Yamato M, Okano T. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des 2009: 15: 2807-14.
5. Peloso A, Dhal A, Zambon JP et al. Current achievements and future perspectives in whole-organ bioengineering. Stem Cell Res Ther 2015: 6: 107.
6. Bulato C, Radu C, Simioni P. Studies on coagulation incompatibilities for xenotransplantation. Methods Mol Biol 2012: 885: 71-89.
7. Cowan PJ, Robson SC, d'Apice AJ. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 2011: 16: 214-21.
8. Fischer-Lougheed J, Gregory C, White Z, Shulkin I, Gunthart M, Kearns-Jonker M. Identification of an anti-idiotypic antibody that defines a B-cell subset(s) producing xenoantibodies in primates. Immunology 2008: 123: 390-7.
9. Li S, Yan Y, Lin Y et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 2007: 110: 3926-35.
10. Reddy V, Jayne D, Close D, Isenberg D. B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design. Arthritis Res Ther 2013: 15 (Suppl 1): S2.
11. Mei HE, Schmidt S, Dorner T. Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity. Arthritis Res Ther 2012: 14 (Suppl 5): S1.
12. Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol 2014: 10: 365-73.
13. Mohiuddin MM, Singh AK, Corcoran PC et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am J Transplant 2014: 14: 488-9.
14. Iwase H, Liu H, Wijkstrom M et al. Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date. Xenotransplantation 2015: 22: 302-9.
15. Le Bas-Bernardet S, Tillou X, Branchereau J et al. Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons. Am J Transplant 2015: 15: 358-70.
16. Hara H, Bentall A, Long C et al. Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study. Xenotransplantation 2013: 20: 429-37.
17. Ierino FL, Sandrin MS. Spectrum of the early xenograft response: from hyperacute rejection to delayed xenograft injury. Crit Rev Immunol 2007: 27: 153-66.
18. Shimizu A, Colvin RB, Yamanaka N. Rejection of peritubular capillaries in renal allo- and xeno-graft. Clin Transplant 2000: 14 (Suppl 3): 6-14.
19. Shimizu A, Yamada K, Robson SC, Sachs DH, Colvin RB. Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol 2012: 23: 225-35.
20. Eich T, Eriksson O, Lundgren T, Nordic Network for Clinical Islet Transplantation. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007: 356: 2754-5.
21. van der Windt DJ, Marigliano M, He J et al. Early islet damage after direct exposure of pig islets to blood: has humoral immunity been underestimated? Cell Transplant 2012: 21: 1791-802.
22. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988: 263: 17755-62.
23. McMorrow IM, Comrack CA, Sachs DH, DerSimonian H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1, 3)Galactose epitope. Transplantation 1997: 64: 501-10.
24. Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Transfus Apher Sci 2006: 35: 45-58.
25. Milland J, Yuriev E, Xing PX, McKenzie IF, Ramsland PA, Sandrin MS. Carbohydrate residues downstream of the terminal Galalpha(1, 3)Gal epitope modulate the specificity of xenoreactive antibodies. Immunol Cell Biol 2007: 85: 623-32.
26. Sharma A, Naziruddin B, Cui C et al. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003: 75: 430-6.
27. Puga Yung GL, Li Y, Borsig L et al. Complete absence of the alphaGal xenoantigen and isoglobotrihexosylceramide in alpha1, 3galactosyltransferase knock-out pigs. Xenotransplantation 2012: 19: 196-206.
28. van der Windt DJ, Bottino R, Casu A et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009: 9: 2716-26.
29. Blixt O, Kumagai-Braesch M, Tibellb A, Groth C, Holgerssonc J. Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays. Am J Transplant 2009: 9: 83-90.
30. Miyagawa S, Maeda A, Kawamura T et al. A comparison of the main structures of N-glycans of porcine islets with those from humans. Glycobiology 2014: 24: 125-38.
31. Kim YG, Gil GC, Jang KS et al. Qualitative and quantitative comparison of N-glycans between pig endothelial and islet cells by high-performance liquid chromatography and mass spectrometry-based strategy. J Mass Spectrom 2009: 44: 1087-104.
32. Stone KR, Walgenbach AW, Turek TJ, Somers DL, Wicomb W, Galili U. Anterior cruciate ligament reconstruction with a porcine xenograft: a serologic, histologic, and biomechanical study in primates. Arthroscopy 2007: 23: 411-9.
33. Xu H, Wan H, Zuo W et al. A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1, 3)-galactose and retention of matrix structure. Tissue Eng Part A 2009: 15: 1807-19.
34. Naso F, Gandaglia A, Iop L, Spina M, Gerosa G. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater 2013: 7: 1728-34.
35. Konakci KZ, Bohle B, Blumer R et al. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005: 35: 17-23.
36. Chen G, Sun H, Yang H et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006: 81: 273-83.
37. Baumann BC, Stussi G, Huggel K, Rieben R, Seebach JD. Reactivity of human natural antibodies to endothelial cells from Galalpha(1, 3)Gal-deficient pigs. Transplantation 2007: 83: 193-201.
38. Diswall M, Angstrom J, Karlsson H et al. Structural characterization of alpha1, 3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 2010: 17: 48-60.
39. Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 2012: 1253: 16-36.
40. Taylor RE, Gregg CJ, Padler-Karavani V et al. Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J Exp Med 2010: 207: 1637-46.
41. Scobie L, Padler-Karavani V, Le Bas-Bernardet S et al. Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol 2013: 191: 2907-15.
42. Basnet NB, Ide K, Tahara H, Tanaka Y, Ohdan H. Deficiency of N-glycolylneuraminic acid and Galalpha1-3Galbeta1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation 2010: 17: 440-8.
43. Lee W, Hara H, Cooper DK, Manji RA. Expression of NeuGc on pig heart valves. Xenotransplantation 2015: 22: 153-4.
44. Barone A, Benktander J, Teneberg S, Breimer ME. Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts. Xenotransplantation 2014: 21: 510-22.
45. Lutz AJ, Li P, Estrada JL et al. Double knockout pigs deficient in N-glycolylneuraminic acid and Galactose alpha-1, 3-Galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013: 20: 27-35.
46. Burlak C, Paris LL, Lutz AJ et al. Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs. Am J Transplant 2014: 14: 1895-900.
47. Park JY, Park MR, Bui HT et al. alpha1, 3-galactosyltransferase deficiency in germ-free miniature pigs increases N-glycolylneuraminic acids as the xenoantigenic determinant in pig-human xenotransplantation. Cell Reprogram 2012: 14: 353-63.
48. Maeda A, Ueno T, Nakatsu S et al. A lectin microarray study of glycoantigens in neonatal porcine islet-like cell clusters. J Surg Res 2013: 183: 412-8.
49. Burlak C, Bern M, Brito AE et al. N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens. Xenotransplantation 2013: 20: 277-91.
50. Yeh P, Ezzelarab M, Bovin N et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010: 17: 197-206.
51. Byrne GW, Du Z, Stalboerger P, Kogelberg H, McGregor CG. Cloning and expression of porcine beta1, 4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation 2014: 21: 543-54.
52. Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest 2000: 105: 301-10.
53. Burlak C, Wang ZY, Chihara RK et al. Identification of human preformed antibody targets in GTKO pigs. Xenotransplantation 2012: 19: 92-101.
54. Chihara RK, Lutz AJ, Paris LL et al. Fibronectin from alpha 1, 3-galactosyltransferase knockout pigs is a xenoantigen. J Surg Res 2013: 184: 1123-33.
55. Byrne GW, Du Z, Sun Z, Asmann YW, McGregor CG. Changes in cardiac gene expression after pig-to-primate orthotopic xenotransplantation. Xenotransplantation 2011: 18: 14-27.
56. Mulder A, Kardol MJ, Arn JS et al. Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. Mol Immunol 2010: 47: 809-15.
57. Ezzelarab M, Garcia B, Azimzadeh A et al. The innate immune response and activation of coagulation in alpha1, 3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009: 87: 805-12.
58. Martin BM, Samy KP, Lowe MC et al. Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction. Am J Transplant 2015: 15: 1241-52.
59. al-Mohanna F, Collison K, Parhar R et al. Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation. Am J Pathol 1997: 151: 111-20.
60. Saleh SM, Parhar RS, Al-Hejailan RS et al. Identification of the tetraspanin CD82 as a new barrier to xenotransplantation. J Immunol 2013: 191: 2796-805.
61. Goto M, Tjernberg J, Dufrane D et al. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 2008: 15: 225-34.
62. Bastian F, Stelzmuller ME, Kratochwill K, Kasimir MT, Simon P, Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials 2008: 29: 1824-32.
63. Kourtzelis I, Ferreira A, Mitroulis I et al. Complement inhibition in a xenogeneic model of interactions between human whole blood and porcine endothelium. Horm Metab Res 2015: 47: 36-42.
64. Resch T, Fabritius C, Ebner S, Ritschl P. Kotsch K. Transplantation: The role of natural killer cells in humoral rejection, 2015.
65. Inverardi L, Pardi R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994: 141: 71-93.
66. Davila E, Byrne GW, LaBreche PT et al. T-cell responses during pig-to-primate xenotransplantation. Xenotransplantation 2006: 13: 31-40.
67. Cozzi E, Vial C, Ostlie D et al. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003: 10: 300-10.
68. Itescu S, Kwiatkowski P, Artrip JH et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998: 59: 275-86.
69. Sommaggio R, Cohnen A, Watzl C, Costa C. Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes. J Immunol 2012: 188: 2075-83.
70. Schneider MK, Ghielmetti M, Rhyner DM, Antsiferova MA, Seebach JD. Human leukocyte transmigration across Galalpha(1, 3)Gal-negative porcine endothelium is regulated by human CD18 and CD99. Transplantation 2009: 87: 491-9.
71. Lilienfeld BG, Garcia-Borges C, Crew MD, Seebach JD. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 2006: 177: 2146-52.
72. Horvath-Arcidiacono JA, Porter CM, Bloom ET. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1, 3)-Gal and killing is enhanced by activation of either effector or target cells. Xenotransplantation 2006: 13: 318-27.
73. Xu XC, Goodman J, Sasaki H, Lowell J, Mohanakumar T. Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am J Transplant 2002: 2: 314-22.
74. Weiss EH, Lilienfeld BG, Muller S et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009: 87: 35-43.
75. Gock H, Murray-Segal LJ, Winterhalter AC et al. Altered glycosylation in donor mice causes rejection of strain-matched skin and heart grafts. Am J Transplant 2014: 14: 797-805.
76. Clatworthy MR, Matthews RJ, Doehler B, Willcocks LC, Opelz G, Smith KG. Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcgammaRIIB-T/T232) does not impact on kidney transplant or recipient survival. Transplantation 2014: 98: 285-91.
77. Yin D, Zeng H, Ma L et al. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol 2004: 172: 7235-8.
78. Wallgren AC, Karlsson-Parra A, Korsgren O. The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte. Transplantation 1995: 60: 594-601.
79. Yi S, Hawthorne WJ, Lehnert AM et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003: 170: 2750-8.
80. Vaithilingam V, Fung C, Ratnapala S et al. Characterisation of the xenogeneic immune response to microencapsulated fetal pig islet-like cell clusters transplanted into immunocompetent C57BL/6 mice. PLoS One 2013: 8: e59120.
81. Kirchhof N, Shibata S, Wijkstrom M et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004: 11: 396-407.
82. Cardona K, Korbutt GS, Milas Z et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006: 12: 304-6.
83. Hering BJ, Wijkstrom M, Graham ML et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006: 12: 301-3.
84. Brown BN, Londono R, Tottey S et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater 2012: 8: 978-87.
85. Hauzenberger E, Hauzenberger D, Hultenby K, Holgersson J. Porcine endothelium supports transendothelial migration of human leukocyte subpopulations: anti-porcine vascular cell adhesion molecule antibodies as species-specific blockers of transendothelial monocyte and natural killer cell migration. Transplantation 2000: 69: 1837-49.
86. Fox A, Mountford J, Braakhuis A, Harrison LC. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol 2001: 166: 2133-40.
87. Thompson P, Badell IR, Lowe M et al. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011: 11: 2593-602.
88. Yi S, Feng X, Hawthorne WJ, Patel AT, Walters SN, O'Connell PJ. CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells. Transplantation 2002: 73: 437-46.
89. Subramanian S, Parthasarathy R, Sen S, Boder ET, Discher DE. Species- and cell type-specific interactions between CD47 and human SIRPalpha. Blood 2006: 107: 2548-56.
90. Ide K, Wang H, Tahara H et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007: 104: 5062-6.
91. Teraoka Y, Ide K, Morimoto H, Tahara H, Ohdan H. Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPalpha inhibitory signaling in mice. PLoS One 2013: 8: e58359.
92. Waern JM, Yuan Q, Rudrich U et al. Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice. Hepatology 2012: 56: 1479-88.
93. Navarro-Alvarez N, Yang YG. Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation. Cell Transplant 2014: 23: 345-54.
94. Kuriyama T, Takenaka K, Kohno K et al. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood 2012: 120: 4058-67.
95. Wang H, Wu X, Wang Y, Oldenborg PA, Yang YG. CD47 is required for suppression of allograft rejection by donor-specific transfusion. J Immunol 2010: 184: 3401-7.
96. Tena A, Kurtz J, Leonard DA et al. Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation. Am J Transplant 2014: 14: 2713-22.
97. del Rio ML, Seebach JD, Fernandez-Renedo C, Rodriguez-Barbosa JI. ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responses. Xenotransplantation 2013: 20: 397-406.
98. Gorczynski RM, Cattral MS, Chen Z et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol 1999: 163: 1654-60.
99. Karlsson-Parra A, Ridderstad A, Wallgren AC, Moller E, Ljunggren HG, Korsgren O. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation 1996: 61: 1313-20.
100. Hering BJ, Walawalkar N. Pig-to-nonhuman primate islet xenotransplantation. Transpl Immunol 2009: 21: 81-6.
101. Dorling A, Lombardi G, Binns R, Lechler RI. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996: 26: 1378-87.
102. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995: 155: 5249-56.
103. Tahara H, Ide K, Basnet N, Tanaka Y, Ohdan H. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes. Xenotransplantation 2010: 17: 188-96.
104. Wilhite T, Ezzelarab C, Hara H et al. The effect of Gal expression on pig cells on the human T-cell xenoresponse. Xenotransplantation 2012: 19: 56-63.
105. Yi S, Feng X, Wang Y, Kay TW, O'Connell PJ. CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway. Transplantation 1999: 67: 435-43.
106. Rogers NJ, Jackson IM, Jordan WJ, Hawadle MA, Dorling A, Lechler RI. Cross-species costimulation: relative contributions of CD80, CD86, and CD40. Transplantation 2003: 75: 2068-76.
107. Park CS, Im SA, Song S, Kim K, Lee CK. Identification of HLA-A2-restricted immunogenic peptides derived from a xenogenic porcine major histocompatibility complex. Xenotransplantation 2014: 21: 465-72.
108. Iwase H, Ekser B, Satyananda V et al. Pig-to-baboon heterotopic heart transplantation - exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation 2015: 22: 211-20.
109. Higginbotham L, Mathews D, Breeden CA et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. Xenotransplantation 2015: 22: 221-30.
110. Griesemer AD, Hirakata A, Shimizu A et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009: 9: 2669-78.
111. Shin JS, Kim JM, Kim JS et al. Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets. Am J Transplant 2015. DOI: 10.1111/ajt.13345. [Epub ahead of print].